Related Experiment Video
Updated: May 16, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Interdisciplinary approach in the management of visual loss in giant cell arteritis
Luca De Simone1, Chiara Marvisi2, Caterina Ricordi2
1Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy.
Insights
Giant cell arteritis (GCA) is a common vasculitis in older adults. Prompt diagnosis and treatment are crucial to prevent severe visual disturbances and sight loss.
Area of Science:
- Rheumatology
- Ophthalmology
- Internal Medicine
Background:
- Giant cell arteritis (GCA) is the most prevalent vasculitis in Western countries, primarily affecting older individuals.
- Glucocorticoids are the primary treatment, necessitating accurate and timely diagnosis.
- Ocular complications, including sudden visual loss, are a significant concern in GCA patients.
Purpose of the Study:
- To review the primary causes of visual disturbances in Giant cell arteritis.
- To highlight critical "red flags" for early detection of sight-threatening complications.
- To emphasize the importance of interdisciplinary collaboration between ophthalmologists and rheumatologists.
Main Methods:
- Literature review focusing on Giant cell arteritis and its ocular manifestations.
- Analysis of diagnostic criteria and treatment protocols for GCA.
- Identification of key clinical indicators associated with visual impairment in GCA.
Main Results:
- Visual disturbances in GCA range from transient symptoms to permanent sight loss.
- Ischemic events are the leading cause of visual complications.
- Early recognition of specific symptoms can significantly improve patient outcomes.
Conclusions:
- An interdisciplinary approach is vital for accurate and timely diagnosis of GCA.
- Recognizing "red flags" aids in preventing irreversible visual loss.
- Prompt initiation of treatment can mitigate the risk of severe ocular complications in GCA.
Abstract:
Giant cell arteritis (GCA) is the most common vasculitis among older patients in western countries. A correct diagnosis permits the prompt initiation of glucocorticoids, which still represent the cornerstone of treatment. One of the most feared complications of the disease is sudden visual loss and other ischemic events causing visual disturbances. In these cases, an interdisciplinary approach between ophthalmologists and rheumatologists is crucial to avoiding any diagnostic delays and to permitting correct clinical assessment without subjecting the patient to unnecessary treatment. In this review, we discuss the main causes of visual disturbances in GCA, particularly the causes of sight loss, outlining the red flags that should raise suspicion in ophthalmologists and rheumatologists.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

